Stay updated on Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction

Sign up to get notified when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.
Latest website image capture
Clouds background image

Latest updates to the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page

  1. Check
    3 days ago
    Change Detected
    Summary
    Footer revision tag updated to Revision: v3.3.2, replacing v3.3.1; no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:39:09.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Publications section wording updated to 'automatically filled from PubMed' and the revision tag changed from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:34:10.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Removal of the government funding lapse notice from the page. The study information remains unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:16:35.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    No significant updates were detected to the study record; only minor textual or layout adjustments may be present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T00:50:11.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T07:52:59.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several safety-focused sections. If these topics were critical, this is a notable reduction in coverage.
    Difference
    0.4%
    Check dated 2025-09-28T02:58:13.000Z thumbnail image

Stay in the know with updates to Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction

Enter your email address, and we'll notify you when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.